The Power of Global Standardization: Unlock High Quality Flow Cytometry Results

Flow Cytometry can interrogate multiparametric measurements on individual cells and has become a widely used specialty testing platform for clinical trials. In addition to the importance of evaluating single-cell analysis throughout the drug development lifecycle, there are increasingly new flow cytometry instruments being introduced that can enhance the researcher’s ability to produce high-quality patient results. One of the challenges that exist when conducting a global clinical trial is the ability to standardize laboratory flow cytometers across sites while also producing rigorous and comparable results in either an exploratory or critical endpoint analysis. Attend this webinar to learn: • Important considerations when designing and validating cytometry panels for use across multiple sites and instruments. • Understanding aspects of flow cytometry assessments in either a regulatory or non-regulatory setting. • Validation of a high-complexity Immuno-Oncology panel to interrogate human patient samples as part of a global clinical trial.